245 related articles for article (PubMed ID: 28710351)
41. Profile of delamanid for the treatment of multidrug-resistant tuberculosis.
Szumowski JD; Lynch JB
Drug Des Devel Ther; 2015; 9():677-82. PubMed ID: 25678771
[TBL] [Abstract][Full Text] [Related]
42. A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies.
Rodríguez-Flores EM; Mata-Espinosa D; Barrios-Payan J; Marquina-Castillo B; Castañón-Arreola M; Hernández-Pando R
PLoS One; 2019; 14(5):e0217457. PubMed ID: 31145751
[TBL] [Abstract][Full Text] [Related]
43. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice.
Liang Q; Xiang H; Li X; Luo C; Ma X; Zhao W; Chen J; Tian Z; Li X; Song X
Int J Nanomedicine; 2020; 15():7491-7507. PubMed ID: 33116484
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis.
Kumar G; Sharma S; Shafiq N; Pandhi P; Khuller GK; Malhotra S
Drug Deliv; 2011 Jan; 18(1):65-73. PubMed ID: 20735202
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models.
Liang Y; Wang X; Song J; Wang L; Chen D; Yang Y; Bai X; Wang J; Shi Y; Chen S; Liu J; Yang C; Luo H; Liu G; Wu X
J Ethnopharmacol; 2017 Jan; 195():318-323. PubMed ID: 27884716
[TBL] [Abstract][Full Text] [Related]
46. An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.
de Faria TJ; Roman M; de Souza NM; De Vecchi R; de Assis JV; dos Santos AL; Bechtold IH; Winter N; Soares MJ; Silva LP; De Almeida MV; Báfica A
Antimicrob Agents Chemother; 2012 May; 56(5):2259-67. PubMed ID: 22330919
[TBL] [Abstract][Full Text] [Related]
47. Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis.
Wolff KA; Nguyen L
Expert Rev Anti Infect Ther; 2012 Sep; 10(9):971-81. PubMed ID: 23106273
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.
Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK
Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349
[TBL] [Abstract][Full Text] [Related]
49. [Present and future in the use of anti-tubercular drugs].
Didilescu C; Craiova UM
Pneumologia; 2011; 60(4):198-201. PubMed ID: 22420168
[TBL] [Abstract][Full Text] [Related]
50. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A
Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438
[TBL] [Abstract][Full Text] [Related]
51. [An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis].
Sukhanov DS; Vinogradova TI; Demidik SN; El'kin AV; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML; Romantsov MG
Eksp Klin Farmakol; 2012; 75(9):32-6. PubMed ID: 23156086
[TBL] [Abstract][Full Text] [Related]
52. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
Toungoussova OS; Mariandyshev AO; Bjune G; Caugant DA; Sandven P
Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):202-6. PubMed ID: 15742171
[TBL] [Abstract][Full Text] [Related]
53. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
54. Clofazimine in the treatment of multidrug-resistant tuberculosis.
Xu HB; Jiang RH; Xiao HP
Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
[TBL] [Abstract][Full Text] [Related]
55. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
de Kantor IN; Barrera L
Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
[TBL] [Abstract][Full Text] [Related]
57. Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis.
Machelart A; Salzano G; Li X; Demars A; Debrie AS; Menendez-Miranda M; Pancani E; Jouny S; Hoffmann E; Deboosere N; Belhaouane I; Rouanet C; Simar S; Talahari S; Giannini V; Villemagne B; Flipo M; Brosch R; Nesslany F; Deprez B; Muraille E; Locht C; Baulard AR; Willand N; Majlessi L; Gref R; Brodin P
ACS Nano; 2019 Apr; 13(4):3992-4007. PubMed ID: 30822386
[TBL] [Abstract][Full Text] [Related]
58. Matryoshka-type gastro-resistant microparticles for the oral treatment of Mycobacterium tuberculosis.
Andreu V; Larrea A; Rodriguez-Fernandez P; Alfaro S; Gracia B; Lucía A; Usón L; Gomez AC; Mendoza G; Lacoma A; Dominguez J; Prat C; Sebastian V; Ainsa JA; Arruebo M
Nanomedicine (Lond); 2019 Mar; 14(6):707-726. PubMed ID: 30734643
[TBL] [Abstract][Full Text] [Related]
59. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
Yew WW; Koh WJ
Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853
[TBL] [Abstract][Full Text] [Related]
60. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
